Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis

被引:0
|
作者
George W. Reed
Robert A. Gerber
Ying Shan
Liza Takiya
Kimberly J. Dandreo
David Gruben
Joel Kremer
Gene Wallenstein
机构
[1] Corrona Research Foundation,
[2] University of Massachusetts Medical School,undefined
[3] Pfizer Inc,undefined
[4] Corrona,undefined
[5] LLC,undefined
[6] Pfizer Inc,undefined
[7] Albany Medical College,undefined
来源
关键词
Anti-TNF; DMARDs (synthetic); Rheumatoid arthritis; Tofacitinib;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:573 / 586
页数:13
相关论文
共 50 条
  • [1] Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis
    Reed, George W.
    Gerber, Robert A.
    Shan, Ying
    Takiya, Liza
    Dandreo, Kimberly J.
    Gruben, David
    Kremer, Joel
    Wallenstein, Gene
    RHEUMATOLOGY AND THERAPY, 2019, 6 (04) : 573 - 586
  • [2] Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis
    Leslie R. Harrold
    George W. Reed
    Jennie Best
    Steve Zlotnick
    Joel M. Kremer
    Rheumatology and Therapy, 2018, 5 : 507 - 523
  • [3] Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis
    Harrold, Leslie R.
    Reed, George W.
    Best, Jennie
    Zlotnick, Steve
    Kremer, Joel M.
    RHEUMATOLOGY AND THERAPY, 2018, 5 (02) : 507 - 523
  • [4] Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia
    Paul Bird
    Geoffrey Littlejohn
    Belinda Butcher
    Tegan Smith
    Catherine O’Sullivan
    David Witcombe
    Hedley Griffiths
    Clinical Rheumatology, 2022, 41 : 53 - 62
  • [5] Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia
    Bird, Paul
    Littlejohn, Geoffrey
    Butcher, Belinda
    Smith, Tegan
    O'Sullivan, Catherine
    Witcombe, David
    Griffiths, Hedley
    CLINICAL RHEUMATOLOGY, 2022, 41 (01) : 53 - 62
  • [6] Comparative effectiveness of tofacitinib and tumour necrosis factor inhibitors in patients with rheumatoid arthritis in real-world practice: a prospective observational study
    Cho, Soo-Kyung
    Song, Yeo-Jin
    Kim, Hye Won
    Nam, Eunwoo
    Jeon, Ja-Young
    Yoo, Hyun-Jeong
    Sung, Yoon-Kyoung
    RHEUMATOLOGY, 2024, 64 (02)
  • [7] Comparative Effectiveness of Tocilizumab Monotherapy with Tumor Necrosis Factor Inhibitors in Combination with Methotrexate in Patients with Rheumatoid Arthritis and Prior Exposure to Tumor Necrosis Factor Inhibitors
    Harrold, Leslie R.
    Reed, George W.
    Best, Jennie
    Zlotnick, Steve
    Persuitte, Gioia
    Kremer, Joel M.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [8] Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis
    Naoki Iwamoto
    Shuntaro Sato
    Shota Kurushima
    Toru Michitsuji
    Shinya Nishihata
    Momoko Okamoto
    Yoshika Tsuji
    Yushiro Endo
    Toshimasa Shimizu
    Remi Sumiyoshi
    Takahisa Suzuki
    Akitomo Okada
    Tomohiro Koga
    Shin-ya Kawashiri
    Keita Fujikawa
    Takashi Igawa
    Toshiyuki Aramaki
    Kunihiro Ichinose
    Mami Tamai
    Hideki Nakamura
    Akinari Mizokami
    Tomoki Origuchi
    Yukitaka Ueki
    Katsumi Eguchi
    Atsushi Kawakami
    Arthritis Research & Therapy, 23
  • [9] Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis
    Iwamoto, Naoki
    Sato, Shuntaro
    Kurushima, Shota
    Michitsuji, Toru
    Nishihata, Shinya
    Okamoto, Momoko
    Tsuji, Yoshika
    Endo, Yushiro
    Shimizu, Toshimasa
    Sumiyoshi, Remi
    Suzuki, Takahisa
    Okada, Akitomo
    Koga, Tomohiro
    Kawashiri, Shin-ya
    Fujikawa, Keita
    Igawa, Takashi
    Aramaki, Toshiyuki
    Ichinose, Kunihiro
    Tamai, Mami
    Nakamura, Hideki
    Mizokami, Akinari
    Origuchi, Tomoki
    Ueki, Yukitaka
    Eguchi, Katsumi
    Kawakami, Atsushi
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [10] Real-world experience with tofacitinib for the treatment of rheumatoid arthritis
    Caporali, Roberto
    Zavaglia, Daniela
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (03) : 485 - 495